Lipella Pharmaceuticals Announces Completion of First Cohort in Phase 2a Trial of LP-310 for Oral Lichen Planus, Advancing to Next Dose Group
November 21, 2024 05:30 ET
|
Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Announces Completion of First Cohort in Phase 2a Trial of LP-310 for Oral Lichen Planus, Advancing to Next Dose Group
Global Down Syndrome Foundation Raises $2.5 Million at Star-Studded Be Beautiful Be Yourself Fashion Show
November 19, 2024 14:27 ET
|
Global Down Syndrome Foundation
Denver, Nov. 19, 2024 (GLOBE NEWSWIRE) -- On Saturday, November 16, Global Down Syndrome Foundation (GLOBAL) raised $2.5 million at their Be Beautiful Be Yourself Fashion Show, held at the Sheraton...
Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index
November 13, 2024 08:00 ET
|
PRISM MarketView
Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index
Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025
November 12, 2024 16:05 ET
|
OncoCyte Corporation
Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025
American Academy of Pediatrics & Global Down Syndrome Foundation Collaborate on Down Syndrome Recommendations
November 12, 2024 14:21 ET
|
Global Down Syndrome Foundation
Denver, Itasca, IL, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Global Down Syndrome Foundation (GLOBAL), the leading Down syndrome research, medical care and advocacy non-profit in the U.S., and the American...
Lipella Pharmaceuticals Secures Extended Market Exclusivity with Issuance of U.S. Patent for Liposomal Delivery Platform
November 12, 2024 05:30 ET
|
Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Secures Extended Market Exclusivity with Issuance of U.S. Patent for Liposomal Delivery Platform
Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12
November 06, 2024 16:45 ET
|
OncoCyte Corporation
Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12
Lipella Pharmaceuticals Announces 1-for-8 Reverse Stock Split
November 01, 2024 16:30 ET
|
Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Announces 1-for-8 Reverse Stock Split
Immunophotonics to Present at the 2024 ThinkEquity Conference
October 28, 2024 08:30 ET
|
Immunophotonics, Inc.
Immunophotonics to Present at the 2024 ThinkEquity Conference
NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity Conference
October 24, 2024 09:00 ET
|
NeuroOne Medical Technologies
NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity Conference